Quantbot Technologies LP Amicus Therapeutics, Inc. Transaction History

Quantbot Technologies LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $189,430 - $275,880	19,000 New	19,000 $269,000
Q1 2023 May 12, 2023	BUY	$10.91 - $13.54 $432,036 - $536,184	39,600 New	39,600 $439,000
Q3 2021 Nov 09, 2021	SELL	$8.74 - $11.84 $143,327 - $194,164	-16,399 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$8.71 - $10.72 $42,626 - $52,463	4,894 Added 42.54%	16,399 $158,000
Q1 2021 May 14, 2021	BUY	$9.2 - $23.86 $105,845 - $274,509	11,505 New	11,505 $113,000
Q2 2020 Aug 13, 2020	SELL	$8.86 - $15.69 $2,720 - $4,816	-307 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$6.63 - $11.16 $62,268 - $104,814	-9,392 Reduced 96.83%	307 $2,000
Q4 2019 Feb 10, 2020	BUY	$7.48 - $10.75 $32,710 - $47,009	4,373 Added 82.11%	9,699 $94,000
Q3 2019 Nov 12, 2019	BUY	$8.02 - $13.25 $208 - $344	26 Added 0.49%	5,326 $42,000
Q2 2019 Aug 13, 2019	BUY	$10.96 - $14.4 $58,088 - $76,320	5,300 New	5,300 $66,000
Q1 2019 May 13, 2019	SELL	$10.04 - $13.92 $23,403 - $32,447	-2,331 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$8.38 - $13.44 $19,533 - $31,328	2,331 New	2,331 $22,000

312

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.68B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.